MEDICATION SAFETY
FDA is cautioning healthcare providers about the safety of dabigatran etexilate (Pradaxa, Boehringer Ingelheim), because of a large clinical trial that showed “serious bleeding events” associated with the anticoagulant. » More |
|
Levonorgestrel (Plan B One-Step, Teva) will remain available by prescription only to adolescents aged 16 years and younger after the Health and Human Services secretary overruled FDA’s recommendation to allow the emergency contraceptive to be sold over the counter. » More |
CLINICAL NEWS
Ranbaxy has launched an authorized generic version of Caduet in the US market, as part of an agreement with Pfizer. » More |
|
A surprisingly few medication classes are responsible for the majority of emergency department visits due to adverse drug reactions among US adults aged 65 years and older, according to a study published in the November 24 issue of the New England Journal of Medicine. » More |
|
Long-term statin use is safe and effective, and it may continue to produce benefits without serious side effects years after patients stop taking the drugs, according to a study published online November 23 in The Lancet. » More |
Editor's Pick
Medication Safety and Reliability
FDA requires several changes to bevacizumab label to include safety information.
» Click here. |
Survey
a) Should be used as first-line therapy in all patients with this diagnosis
b) Reserved as first-line therapy for only those patients who are unable to take warfarin due to contraindications
c) Reserved for second-line use only in those patients who have failed warfarin due to unmanageable side effects, lack of efficacy, and/or inability to maintain adequate INRs
d) b & c
e) Leave it entirely up to discretion of the clinician based upon individual patient circumstances
Respond here and see what your colleagues think too.
Want to see the results of our last survey regarding specialty pharmacies and their service offerings?
Click here. |
|
Abciximab plus unfractionated heparin was no more effective than bivalirudin at reducing risk of death or other events for patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention, according to a study published online November 24 in the New England Journal of Medicine. » More |
|
Adolescent girls with a family history of breast cancer who drink alcohol are at an increased risk for benign breast disease as young women, according to a study published November 14 in Cancer.
» More |
|
Confirm your
e-newsletter subscription click here.
To ensure future delivery of email newsletters from Formulary please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff |
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|
